Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?

Hot topics
Chairs: O. Usmani (London, United Kingdom), A. Simonds (London, United Kingdom)
Aims: To describe the role of novel therapies for airway diseases, namely, asthma, chronic obstructive pulmonary disease (COPD) and chronic cough; to describe the essential role of artificial intelligence, which will revolutionise how doctors follow and treat patients; to address common problems related to novel therapies and artificial intelligence in everyday practice in order to improve patient care.

Will we really achieve anti-ageing lung treatments? Abnormal lung ageing in COPD C. Brandsma (Groningen, Netherlands)
Who should receive which biologic and why? Current and future approaches in severe asthma patients P. Nair (Hamilton (ON), Canada)
Will we ever be successful? Managing T2-low asthma A. Ten Brinke (Leeuwarden, Netherlands)
What is the scientific and clinical rationale? Triple therapy in COPD patients D. Singh (Manchester, United Kingdom)
Discussion and Q&A